Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMNB
2476
DELISTED
American National Bankshares Inc
AMNB
| $3.94M | ﹤0.01% |
157,221
+4,236
| +3% | +$101K |
|
2477
Willdan Group
WLDN
$1.16B
| $3.93M | ﹤0.01% |
157,056
+3,471
| +2% | +$79.8K |
|
2478
CNB Financial Corp
CCNE
$1.06B
| $3.92M | ﹤0.01% |
218,911
+7,435
| +4% | +$126K |
|
|
SPNE
2479
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $3.92M | ﹤0.01% |
374,267
+47,389
| +14% | +$485K |
|
2480
Hingham Institution for Saving
HIFS
$668M
| $3.89M | ﹤0.01% |
23,187
+451
| +2% | +$70K |
|
2481
UroGen Pharma
URGN
$1.94B
| $3.89M | ﹤0.01% |
148,917
+11,332
| +8% | +$277K |
|
|
TRUE
2482
DELISTED
TrueCar
TRUE
| $3.88M | ﹤0.01% |
1,504,568
+48,461
| +3% | +$124K |
|
2483
Surgery Partners
SGRY
$2.05B
| $3.88M | ﹤0.01% |
335,021
+10,867
| +3% | +$119K |
|
|
BFX
2484
DELISTED
BowFlex Inc.
BFX
| $3.87M | ﹤0.01% |
417,798
+210,097
| +101% | +$1.27M |
|
|
BRY
2485
DELISTED
Berry Corp
BRY
| $3.87M | ﹤0.01% |
800,852
+52,455
| +7% | +$203K |
|
2486
Tucows
TCX
$162M
| $3.87M | ﹤0.01% |
67,474
+1,910
| +3% | +$106K |
|
2487
XPEL
XPEL
$1.27B
| $3.86M | ﹤0.01% |
247,013
+96,823
| +64% | +$1.32M |
|
2488
Donnelley Financial Solutions
DFIN
$1.22B
| $3.85M | ﹤0.01% |
458,545
+8,277
| +2% | +$59.6K |
|
|
HTB
2489
HomeTrust Bancshares
HTB
$871M
| $3.85M | ﹤0.01% |
240,682
+5,061
| +2% | +$76.1K |
|
2490
Equity Bancshares
EQBK
$1.06B
| $3.85M | ﹤0.01% |
220,706
+4,197
| +2% | +$69.4K |
|
2491
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
| – | – |
0
| – | – |
|
|
AMAG
2492
DELISTED
AMAG Pharmaceuticals
AMAG
| $3.82M | ﹤0.01% |
499,916
-571
| -0.1% | -$4.37K |
|
|
RAPT
2493
DELISTED
RAPT Therapeutics
RAPT
| $3.81M | ﹤0.01% |
16,425
+7,606
| +86% | +$1.18M |
|
2494
Stoke Therapeutics
STOK
$1.97B
| $3.81M | ﹤0.01% |
159,944
-25,912
| -14% | -$615K |
|
|
SLCA
2495
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $3.81M | ﹤0.01% |
1,055,016
+38,266
| +4% | +$96.6K |
|
|
GSKY
2496
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $3.8M | ﹤0.01% |
775,480
+389,593
| +101% | +$1.67M |
|
2497
NWPX Infrastructure Inc
NWPX
$1.22B
| $3.79M | ﹤0.01% |
151,303
+2,306
| +2% | +$54.9K |
|
|
TCRR
2498
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $3.75M | ﹤0.01% |
244,508
+53,004
| +28% | +$611K |
|
|
HCCI
2499
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $3.75M | ﹤0.01% |
214,510
+4,904
| +2% | +$82.6K |
|
2500
Peoples Financial Services
PFIS
$721M
| $3.73M | ﹤0.01% |
97,824
+9,735
| +11% | +$338K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.